z-logo
open-access-imgOpen Access
Two-Stage Revascularization in Patients with Acute Myocardial Infarction and Massive Coronary Thrombosis
Author(s) -
Е. В. Вышлов,
А. Л. Крылов,
А. Г. Сыркина,
Ya. V. Alexeeva,
S. V. Demyanov,
A. Baev,
В. А. Марков,
V. V. Ryabov
Publication year - 2019
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2019.2.10224
Subject(s) - medicine , timi , cardiology , conventional pci , myocardial infarction , percutaneous coronary intervention , revascularization , thrombus , antithrombotic , thrombosis , stenosis , artery , coronary thrombosis , surgery
Aim: to investigate safety and angiographic efficacy of two-stage revascularization with percutaneous coronary intervention (PCI) with stenting delayed by one day in patients with acute myocardial infarction (MI) and massive coronary thrombosis. Materials and methods. We included in this study 12 patients with massive infarct related coronary artery thrombus which length was greater than thrice the vessel diameter in the presence of TIMI grade II–III blood flow as detected by coronary angiography (CAG). The emergency PCI was not performed, and conservative antithrombotic therapy continued for 24 hours. After this day, CAG was repeated. Results. Repeat CAG in all patients showed thrombus regression which visually appeared as complete lysis in 8, and partial lysis – in 4 patients. Stenting of residual stenosis was performed in 11 patients without complications. In 1 patient residual stenosis was considered insignificant (<50 %) therefore stenting was not performed. No-reflowphenomenon and recurrent MI were not observed. Conclusion. These data suggest that in patients with massive coronary artery thrombosis conservative antithrombotic therapy for 24 hours followed by repeated CAG and, if required, by stenting of residual stenosis, is safe treatment tactics that might reduce the risk of the no-reflow phenomenon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here